Explore our curated collection of technical analyses and commercial scale-up strategies specifically focused on Brevibacterium flavum. These insights are designed to support R&D and procurement teams in optimizing their supply chains.
Patent CN100385007C details a microbial method for (R)-mandelic acid using Brevibacterium flavum, offering high optical purity and scalable biocatalysis for pharma intermediates.